Return to homepagePandemic Pact

CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.

  • Funded by Biomedical Advanced Research and Development Authority (BARDA)
  • Total publications:0 publications

Grant number: 75A50120C00009

Grant search

Key facts

  • Disease

    Ebola

  • Start & end year

    2020
    2023

  • Known Financial Commitments (USD)

    $20,196,134.88

  • Funder

    Biomedical Advanced Research and Development Authority (BARDA)

  • Research Location

    United States of America

  • Lead Research Institution

    RIDGEBACK BIOTHERAPEUTICS LP

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    N/A

Abstract

CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.